The Uptake and Metabolism of Cyclophosphamide by the Ovary
- 1 January 1990
- journal article
- research article
- Published by Mary Ann Liebert Inc in Selective Cancer Therapeutics
- Vol. 6 (2) , 83-92
- https://doi.org/10.1089/sct.1990.6.83
Abstract
The uptake of cyclophosphamide (CTX) and its metabolites was evaluated by injecting adult femal rats with 14C-CTX on the morning of metestrous or proestrus. Rats were sacrificed 1 and 5 hours after 14C-CTX injection. The ovary, uterus, spleen, thymus, liver, kidney, anterior pituitary, duodenum, skeletal muscle and whole blood were isolated from each rat. Samples were combusted using a biological material oxidizer and the resulting CO2 was absorbed and counted. Liver and kidney had the highest uptake of 14C-radio-activity. The ovary appears to have 14C uptake comparable to the thymus and other tissues. Metabolism of CTX by the ovary was investigated by incubating 14C-CTX with human and rat granulosa cells and other ovarian cells obtained from pregnant mares' serum gonadotropin (PMSG)-primed immature rats, in separate experiments. The conversion of CTX to two marker metabolites, 4-ketocyclo-phosphamide and 4-hydroxycyclophosphamide was negligible and did not change in the presence of luteinizing hormone (LH). It is concluded that 1) following 14C-CTX injection, the ovary takes up a proportion of 14C-radioactivity comparable to other target tissues (e.g. thymus) and 2) the ovary is not capable of activating CTX in vitro in our system.Keywords
This publication has 2 references indexed in Scilit:
- The effect of “activated” cyclophosphamide on rat granulosa cells in vitroReproductive Toxicology, 1988
- Long‐term cyclophosphamide therapy in rheumatoid arthritisArthritis & Rheumatism, 1968